Statistical analysis shows glymphatic dysfunction mediates cognitive decline in Parkinson’s patients, indicating important relationships.
Motivation: To explore the potential factors of cognitive decline in patients with Parkinson's disease (PD). Goal(s): Whether glymphatic makers mediate the relationship between sleep distorder/neuroinflammation and cognitive performance in PD patients. Approach: Statistical methods used partial correlation analysis and mediation analysis. Results: Glymphatic markers as a significant mediator between sleep disorder/ neuroinflammation between cognitive performanceon on PD participants. Impact: Our study provided evidence that both sleep disorder and neuroinflammation were associated with glymphatic dysfunction, which is further related to cognitive impairment. These results may provide a theoretical basis for new targets for treating PD.
No takes yet. Share an insight, caveat, or question.
张 et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: